Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Post Reprod Health ; 24(4): 163-165, 2018 12.
Article in English | MEDLINE | ID: mdl-30348046

ABSTRACT

Cancer treatment may result in loss of ovarian function through surgical removal of the ovaries, chemotherapy or radiation. While menopausal symptoms, such as hot flushes, night sweats, sleep disturbance, memory concerns and mood issues can be extremely bothersome to some women going through menopause naturally, women who undergo an induced menopause usually experience more sudden and severe symptoms. Pain and vaginal dryness can occur whether a woman has a sexual partner or not. In women with breast cancer, the aetiology of impaired sexual functioning, and lowered sexual desire, is often multifactorial, and may be related to physical and/or psychological reasons. Pain and vaginal dryness in women without a history of breast cancer can usually be safely treated with vaginal estrogens, in the form of a cream, pessary or ring, and simple lubricants or vaginal moisturisers. Safe usage of vaginal estrogen replacement therapy in breast cancer patients has not been studied within randomised clinical trials of long duration; the guidelines below reflect a clinical consensus.


Subject(s)
Breast Neoplasms , Menopause, Premature , Patient Care Management/methods , Vagina , Vulva , Atrophy/etiology , Atrophy/therapy , Breast Neoplasms/complications , Breast Neoplasms/therapy , Estrogen Replacement Therapy/methods , Female , Humans , Menopause, Premature/physiology , Menopause, Premature/psychology , United Kingdom , Vagina/pathology , Vagina/physiopathology , Vaginal Creams, Foams, and Jellies/pharmacology , Vulva/pathology , Vulva/physiopathology
2.
Menopause Int ; 16(2): 68-73, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20729498

ABSTRACT

Vaginismus is generally described as an involuntary contraction of the vaginal musculature, which usually results in the failure of penetration. Despite a lack of consensus as to the exact definition, prevalence rates vary between 4.2% and 42%. It is commonly diagnosed at both gynaecological and psychosexual clinics. The majority of studies and treatment options concentrate on the premenopausal age group. It is accepted that even within this age group, the diagnosis is often incorrect as symptoms can be confused with dyspareunia and other sexual pain disorders. There is no literature discussing vaginismus in the postmenopausal patient, despite evidence that an active sex life is important to the majority of women, irrespective of age. It is known that the majority of women do not report difficulties in their sex life and it may be that the older patient is more embarrassed at disclosing any such difficulties. This review aims to highlight the possible causes of vaginismus in this older age group and to aid the clinician in asking the appropriate questions, performing the appropriate examination and suggesting possible treatment options.


Subject(s)
General Practitioners , Perimenopause/physiology , Postmenopause/physiology , Vaginismus/diagnosis , Vaginismus/etiology , Dyspareunia/diagnosis , Estrogen Replacement Therapy , Female , Humans , Practice Guidelines as Topic , Sexual Behavior/physiology , Sexual Behavior/psychology , Vagina/physiology , Vaginismus/classification , Vaginismus/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...